SNOO Smart Sleeper Bassinet Wins FDA Clearance
Executive Summary
The $1,700 infant sleeper is the first device to reach market indicated to help babies sleep on their backs. It was developed by Happiest Baby.
You may also be interested in...
Could Bassinet Clearance Expand FDA Authority? Law Firm Expresses Concern
By clearing Happiest Baby’s SNOO bassinet in March, the US FDA exercised authority over a product that typically would fall within the jurisdiction of consumer product safety regulators. One law firm questions what that might mean for manufacturers of similar products.
US study questions home monitors for SIDS (sudden infant death syndrome)
US researchers have found that home monitoring systems designed to pick up tell-tale signs associated with sudden infant death syndrome (SIDS), such as apnoea, may not be able to identify the majority of extreme cases.
Addition to Quest Alzheimer's Suite Looks For Biomarker P-Tau217
The test is being integrated into Quest’s AD-Detect portfolio for assessing the risk of Alzheimer’s. It is the third p-tau217 test to make news this month, after new breakthrough designations for Quanterix and Roche and Eli Lilly.